O'Melveny
We only have limited information for this firm. Consider the following firms which have provided more information:
Praised by clients for their bench strength, the team at O'Melveny handles a variety of matters, including carve-outs, going-privates, and joint ventures. The group is known for acting in biopharma and biotech companies on inbound and outbound investments. ‘Outstanding' practice co-head Nima Amini acts as the managing partner of the Hong Kong office, in addition to advising on cross border transactions across Europe, the US, and the APAC region. Edwin Kwok regularly assists clients with securities offerings, regulated listings as notifiable transactions, and public takeovers.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The OMM team are outstanding. The firm has great bench strength is very responsive and very commercial.’
‘Nima Amini is an outstanding practitioner. He is very knowledgeable on key laws but importantly is very commercial, practical and a great communicator. He has assembled a great team around him, including Nolan Shaw who is a true young gun, and in whose hands we always feel safe. ’
Abbreviated data is displayed for this firm.
Key clients
- Acotec Scientific
- Lazada and Alibaba
Abbreviated data is displayed for this firm.
Work highlights
- Advised Acotec Scientific Holdings Limited (6669.HK) on the voluntary partial offer by Boston Scientific Group plc.
- Advised Lazada, a subsidiary of Alibaba Group Holding, in connection with its US$375 m equity investment in PT ELANG ANDALAN NUSANTARA.
Abbreviated data is displayed for this firm.